Related Experiment Video

Updated: Jun 10, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

Increased platelet, leukocyte and endothelial microparticles predict enhanced coagulation and vascular inflammation

Philipp Diehl1, Miriam Aleker, Thomas Helbing

  • 1Department of Cardiology and Angiology, University Hospital Freiburg, Hugstetterstr 55, 79106 Freiburg, Germany. philipp.diehl@uniklinik-freiburg.de

Journal of Thrombosis and Thrombolysis
|August 4, 2010
PubMed

Insights

Pulmonary hypertension (PH) patients show elevated levels of platelet- and leukocyte-derived microparticles (MPs), indicating increased vascular inflammation and coagulation. These microparticles may predict life-threatening thrombo-embolic complications in PH.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Cell Biology

Background:

  • Pulmonary hypertension (PH) is linked to platelet activation, vascular inflammation, and endothelial dysfunction, often leading to severe thrombo-embolic events.
  • Microparticles (MPs) are cell-derived vesicles implicated in coagulation and inflammation, released during cellular activation or apoptosis.
  • Current diagnostic methods lack reliable markers for platelet activation and pro-coagulation status in PH patients.

Purpose of the Study:

  • To investigate circulating pro-coagulatory microparticle populations in pulmonary hypertension (PH) patients.
  • To determine if specific microparticle types correlate with thrombo-embolic complications in PH.
  • To explore potential surrogate markers for platelet activation and coagulation in PH.

Main Methods:

  • Quantification of circulating platelet-derived MPs (PMP), leukocyte-derived MPs (LMP), and endothelial-derived MPs (EMP) using flow cytometry.
  • Comparison of MP levels between 19 PH patients and 16 healthy controls.
  • Analysis of correlations between different MP types and between MP levels and thrombo-embolic status in PH patients.

Main Results:

  • PH patients exhibited significantly higher levels of PMP, LMP, and EMP compared to controls.
  • Significant correlations were observed between PMP and LMP, and between LMP and EMP, suggesting functional interactions.
  • Patients with thrombo-embolic PH showed markedly elevated EMP levels compared to non-embolic PH patients, indicating enhanced endothelial dysfunction.

Conclusions:

  • Elevated levels of platelet-, leukocyte-, and endothelial-derived MPs in PH patients suggest increased vascular pro-coagulation and inflammation.
  • These microparticle populations may serve as indicators of thrombo-embolic risk and potential contributors to PH progression.
  • Further research into MPs could lead to novel diagnostic and therapeutic strategies for managing PH and its complications.

More Related Videos

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)04:56

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Published on: August 4, 2023

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.